Buchumschlag

Projecting pharmaceutical expenditure in EU5 to 2021: adjusting for the impact of discounts and rebates

Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expenditure—driven by high prices—will be unsustainable unless further reforms are enacted.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Espin, Jaime (VerfasserIn) , Schlander, Michael (VerfasserIn) , Godman, Brian (VerfasserIn) , Anderson, Pippa (VerfasserIn) , Mestre Ferrándiz, Jorge (VerfasserIn) , Borget, Isabelle (VerfasserIn) , Hutchings, Adam (VerfasserIn) , Flostrand, Steven (VerfasserIn) , Parnaby, Adam (VerfasserIn) , Jommi, Claudio (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 7 August 2018
In: Applied health economics and health policy
Year: 2018, Jahrgang: 16, Heft: 6, Pages: 803-817
ISSN:1179-1896
DOI:10.1007/s40258-018-0419-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s40258-018-0419-1
Volltext
Verfasserangaben:Jaime Espin, Michael Schlander, Brian Godman, Pippa Anderson, Jorge Mestre-Ferrandiz, Isabelle Borget, Adam Hutchings, Steven Flostrand, Adam Parnaby, Claudio Jommi
Beschreibung
Zusammenfassung:Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expenditure—driven by high prices—will be unsustainable unless further reforms are enacted.
Beschreibung:Gesehen am 02.04.2020
Beschreibung:Online Resource
ISSN:1179-1896
DOI:10.1007/s40258-018-0419-1

Ähnliche Einträge